Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis

• Chen I. Tseng,
• Alistair J. Roddick,
• Matthew J. Bottomley,
• Susan Shapiro,
• Udaya Udayaraj

Affiliations

Chen I. Tseng

Oxford Kidney Unit, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

Alistair J. Roddick

Oxford Kidney Unit, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

Matthew J. Bottomley

Oxford Kidney Unit, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

Susan Shapiro

Oxford Haemophilia and Thrombosis Centre, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

Udaya Udayaraj

Oxford Kidney Unit, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK